abs55.txt	androgen	receptor	splice	variant	7	(ar-v7)	is	crucial	for	prostate	cancerprogression	and	therapeutic	resistance		we	show	that	independent	of	ligand	ar-v7	binds	both	androgen-responsive	elements	(ares)	non-canonical	sitesdistinct	from	full-length	ar	(ar-fl)	targets	consequently	not	onlyrecapitulates	ar-fl's	partial	functions	but	also	regulates	an	additional	geneexpression	program	uniquely	via	binding	to	gene	promoters	rather	than	areenhancers	ar-v7-mediated	activation	at	these	unique	donot	require	foxa1	rely	on	zfx	brd4	knockdown	or	select	uniquetargets	ar-v7/zfx	inhibition	suppresses	growth	ofcastration-resistant	cancer	cells	define	direct	targetgene	signature	correlates	with	expression	in	primary	tumors	differentiates	metastatic	normal	predicts	poorprognosis	thus	has	are/foxa1	canonical	zfx-directednon-canonical	regulatory	the	evolution	anti-androgen	therapeuticresistance	providing	information	guide	effective	strategies
